Diagnosis and Management of Testicular Cancer
-15%
portes grátis
Diagnosis and Management of Testicular Cancer
The European Point of View
Krege, Susanne
Springer International Publishing AG
10/2016
135
Mole
Inglês
9783319359632
15 a 20 dias
This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field.
Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group.- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI?.- Is there still an indication for diagnostic RPLND in nonseminoma CSI?.- How could the prognosis of patients with intermediate risk disease be improved?.- How should patients with poor-prognosis disease be treated actually?.- How should patients with recurrent disease be treated actually?.- How important are prognostic factors for determining treatment in patients with primary or recurrent disease?.- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma?.- How should residual disease outside the retroperitoneum be treated?.- What are the recent recommendations for follow up in testicular cancer?.- What are the long-term toxicities to be controlled and treated?.- Consequences of the disease and its treatment concerning sexuality and fertility.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field.
Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group.- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI?.- Is there still an indication for diagnostic RPLND in nonseminoma CSI?.- How could the prognosis of patients with intermediate risk disease be improved?.- How should patients with poor-prognosis disease be treated actually?.- How should patients with recurrent disease be treated actually?.- How important are prognostic factors for determining treatment in patients with primary or recurrent disease?.- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma?.- How should residual disease outside the retroperitoneum be treated?.- What are the recent recommendations for follow up in testicular cancer?.- What are the long-term toxicities to be controlled and treated?.- Consequences of the disease and its treatment concerning sexuality and fertility.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
